GlassScriptPhysician profile
Amar A Nath
NPI 1881676823
$1,003.74
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $530 · 2020: $166 · 2021: $110 · 2022: $198.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $261.04 | 2019-2021 | |
| Astellas Pharma US INC | $198.00 | 2022 | |
| Janssen Pharmaceuticals, INC | $87.81 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $87.16 | 2019-2020 | |
| Pfizer INC. | $57.38 | 2019-2020 | |
| Amgen INC. | $47.40 | 2019-2021 | |
| Abbott Laboratories | $35.70 | 2021 | |
| Lundbeck LLC | $34.97 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $29.61 | 2020 | |
| Sanofi-Aventis U.S. LLC | $29.43 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $27.27 | 2019 | |
| Lantheus Medical Imaging, INC. | $24.54 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.96 | 2019-2020 | |
| Biotronik INC. | $19.99 | 2019 | |
| Esperion Therapeutics, INC. | $14.20 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $13.07 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.21 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amar Nath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.